MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbott, G. W.
Right arrow Articles by Goldstein, S. A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbott, G. W.
Right arrow Articles by Goldstein, S. A. N.
Review

Potassium Channel Subunits: The MiRP Family

Geoffrey W. Abbott and Steve A. N. Goldstein

Departments of Pediatrics and Cellular and Molecular Physiology Boyer Center for Molecular Medicine Yale University School of Medicine New Haven, CT 06536

Correspondence: Address correspondence to SANG. E-mail steve.goldstein{at}yale.edu; fax 203-737-2290.


{GOLDSTEINOPENING1x}

The electrocardiogram shown above demonstrates an arrhythmia, called torsades de pointes (sinusoidal trace at right), that is incompatible with the normal pump function of the heart. This particular case was drug-induced and reflects the impairment of specific potassium channels that normally promote the repolarization phase of the cardiac action potential. New insights into the mutations and drugs that compromise the cellular flux of potassium, not only in the heart but also in other organs, are being gained through investigations of the protein components of voltage-gated potassium channels.

Voltage-gated potassium channels provide tightly Controlled, ion-specific pathways across membranes and are key to the normal function of nerves muscles. They arise from the assembly of four pore-forming proteins called {alpha}-subunits. To attain the properties of native currents, {alpha}-subunits interact with additional molecules such as the mink-related peptides (MiRPs), single-transmembrane subunits encoded by the KCNE genes. Significantly, mutations in KCNE 1, 2 and 3 have been linked either to life-threatening cardiac arrhythmia or a disorder of skeletal muscle, familial periodic paralysis. The capacity of MiRPs to partner with multiple {alpha}-subunits in experimental cells appears to reflect still undiscovered roles for the KCNE-encoded peptides in vivo. Here, we consider these unique peptides in health disease and discuss future research directions.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. Gao, Q. Xiong, H. Sun, and M. Li
Desensitization of Chemical Activation by Auxiliary Subunits: CONVERGENCE OF MOLECULAR DETERMINANTS CRITICAL FOR AUGMENTING KCNQ1 POTASSIUM CHANNELS
J. Biol. Chem., August 15, 2008; 283(33): 22649 - 22658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Wiener, Y. Haitin, L. Shamgar, M. C. Fernandez-Alonso, A. Martos, O. Chomsky-Hecht, G. Rivas, B. Attali, and J. A. Hirsch
The KCNQ1 (Kv7.1) COOH Terminus, a Multitiered Scaffold for Subunit Assembly and Protein Interaction
J. Biol. Chem., February 29, 2008; 283(9): 5815 - 5830.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. C. L. Bett and R. L. Rasmusson
Modification of K+ channel-drug interactions by ancillary subunits
J. Physiol., February 15, 2008; 586(4): 929 - 950.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
D. Heitzmann and R. Warth
No Potassium, No Acid: K+ Channels and Gastric Acid Secretion
Physiology, October 1, 2007; 22(5): 335 - 341.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Mustapha, L. Pang, and S. Nattel
Characterization of the cardiac KCNE1 gene promoter
Cardiovasc Res, January 1, 2007; 73(1): 82 - 91.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
Y. Li, S. Y. Um, and T. V. Mcdonald
Voltage-Gated Potassium Channels: Regulation by Accessory Subunits
Neuroscientist, June 1, 2006; 12(3): 199 - 210.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
J. M. Nerbonne and R. S. Kass
Molecular Physiology of Cardiac Repolarization
Physiol Rev, October 1, 2005; 85(4): 1205 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Liao, L. Wang, S. T. Halm, L. Lu, R. E. W. Fyffe, and D. R. Halm
K+ channel KVLQT1 located in the basolateral membrane of distal colonic epithelium is not essential for activating Cl- secretion
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C564 - C575.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Qu, Y. Kryukova, I. A. Potapova, S. V. Doronin, M. Larsen, G. Krishnamurthy, I. S. Cohen, and R. B. Robinson
MiRP1 Modulates HCN2 Channel Expression and Gating in Cardiac Myocytes
J. Biol. Chem., October 15, 2004; 279(42): 43497 - 43502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Krumerman, X. Gao, J.-S. Bian, Y. F. Melman, A. Kagan, and T. V. McDonald
An LQT mutant minK alters KvLQT1 trafficking
Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1453 - C1463.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
H. Chen, F. Sesti, and S. A. N. Goldstein
Pore- and State-Dependent Cadmium Block of IKs Channels Formed with MinK-55C and Wild-Type KCNQ1 Subunits
Biophys. J., June 1, 2003; 84(6): 3679 - 3689.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. W. ABBOTT and S. A. N. GOLDSTEIN
Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanism
FASEB J, March 1, 2002; 16(3): 390 - 400.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.